Reference health
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial
32489-4/badge.svg){kind=icon}
30/30 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 30 checked references that resolve
resolves10.1136/rmdopen-2015-000166
Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt– a national health survey
resolves10.1093/aje/kwf141
Prevalence of Symptomatic Hand Osteoarthritis and Its Impact on Functional Status among the Elderly: The Framingham Study
resolves10.1002/art.40097
Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project
resolves10.1136/ard.2010.131151
Assessing health-related quality of life in hand osteoarthritis: a literature review
resolves10.1038/s41584-018-0095-4
Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management
resolves10.1136/ard.2007.084772
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT
resolves10.1038/nrrheum.2013.214
Hand osteoarthritis—nonpharmacological and pharmacological treatments
resolves10.1136/rmdopen-2018-000734
Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis
resolves10.1136/annrheumdis-2018-213826
2018 update of the EULAR recommendations for the management of hand osteoarthritis
resolves10.1002/art.1780331101
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand
resolves10.1136/annrheumdis-2015-208823
Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis
resolves10.1002/art.1780390221
Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints
resolves10.1136/ard.2007.077081
The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritis
resolves10.3899/jrheum.131086
Iterative Development and Reliability of the OMERACT Hand Osteoarthritis MRI Scoring System
resolves10.1016/j.joca.2004.02.001
OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
resolves10.1093/rheumatology/kes219
A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis
resolves10.1136/ard.2007.074401
Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis
resolves10.3899/jrheum.140736
Effectiveness of Triamcinolone Hexacetonide Intraarticular Injection in Interphalangeal Joints: A 12-week Randomized Controlled Trial in Patients with Hand Osteoarthritis
resolves10.1016/j.berh.2018.08.007
Thumb base osteoarthritis: A hand osteoarthritis subset requiring a distinct approach
resolves10.1038/nrrheum.2010.196
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
resolves10.1136/ard.2006.061861
Response to intramuscular methyl prednisolone in inflammatory hand pain: evidence for a targeted clinical, ultrasonographic and therapeutic approach
resolves10.1007/s001980200108
The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis
resolves10.1136/annrheumdis-2013-203249
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
resolves10.1136/bmj.c7086
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
resolves10.7326/0003-4819-115-10-787
Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
resolves10.1016/S0140-6736(13)60900-9
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/s0140-6736(19)32489-4"><img src="https://citestamp.com/citestamped/10.1016/s0140-6736(19)32489-4/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[32489-4/badge.svg)](https://citestamp.com/citestamped/10.1016/s0140-6736(19)32489-4)